Sunny D Insta 5 mg / 1 ml Injection – Vitamin D3 Ampoule

Description

Sunny D Insta injection is a high-dose Vitamin D3 (cholecalciferol) formulation used to treat or prevent vitamin D deficiency, especially when oral administration is not feasible or in cases of malabsorption. Each 1 ml ampoule contains 5 mg (200,000 IU) of Vitamin D3. 

Ingredients

• Active ingredient: Cholecalciferol (Vitamin D3), 5 mg per 1 ml ampoule (~200,000 IU) 

• Inactive / excipients: (manufacturer’s formulation including solvent, stabilizers, etc.) — check official leaflet.

Drug Class

Vitamin D analog / Nutritional supplement / Fat-soluble vitamin 

Dosage Form

Injection (sterile solution) — 1 ml ampoule containing 5 mg cholecalciferol (Vitamin D3) 

Uses (Indications)

Sunny D Insta is used for:

• Correction of Vitamin D deficiency, especially in patients who cannot take oral supplements 

• Cases of malabsorption, chronic liver disease, or when oral uptake is compromised 

• Support for bone health, calcium metabolism, and maintenance of normal vitamin D levels 

Dosage

• The dose is high (5 mg / 200,000 IU) in a single ampoule; the exact regimen or frequency is determined by the physician based on the patient’s deficiency severity, baseline vitamin D levels, and risk factors. 

• Such high-dose injections are typically not repeated frequently; follow monitoring guidelines (e.g. checking serum 25(OH)D, calcium) before further dosing.

In Case of Overdose

• Excessive vitamin D can lead to hypercalcemia — symptoms may include nausea, vomiting, weakness, frequent urination, kidney stones, confusion.

• Management: Stop supplementation, restrict dietary calcium, hydrate, monitor and treat hypercalcemia under medical supervision.

Missed Dose

• In a clinical setting, missing an injection should be addressed by the treating physician.

• Do not self-administer or double the dose to compensate.

How To Use / Administration

• Administer via intramuscular (IM) injection (often recommended for depot effect) or as per manufacturer instructions.

• Use aseptic technique.

• Monitor patients during and after injection for adverse events, especially in cases of underlying conditions (kidney, calcium metabolism).

When Not to Use (Contraindications)

• Hypercalcemia or hypervitaminosis D

• Severe renal impairment or nephrolithiasis

• Known hypersensitivity to vitamin D or any component of formulation

• Disorders of calcium metabolism (unless under careful monitoring)

• Use with caution in pregnancy or lactation — only if clearly needed

Side Effects

Common / Less serious:

• Mild hypercalcemia symptoms (thirst, urination)

• Gastrointestinal discomfort

• Headache

Less common / Serious:

• Hypercalcemia and associated complications (renal stones, bone pain)

• Soft tissue calcification

• Allergic reactions

Precautions & Warnings

• Monitor serum calcium, phosphate, magnesium after injection

• Check renal function

• Avoid excessive concurrent intake of calcium or vitamin D

• Be cautious in patients with cardiovascular disease, kidney disease, or predisposition to hypercalcemia

• Adjust or avoid in patients using thiazide diuretics (which can increase calcium reabsorption)

Drug Interactions

• Thiazide diuretics — may potentiate hypercalcemia

• Digoxin — altered calcium levels may affect cardiac rhythm

• Magnesium supplements, calcium supplements — risk of additive hypercalcemia

• Some anticonvulsants (e.g. phenobarbital, phenytoin) — may increase vitamin D metabolism

Storage / Disposal

• Store at controlled room temperature, away from light, heat, and moisture (often ≤ 30 °C) 

• Do not freeze

• Use before expiration

• Dispose unused ampoules according to medical waste regulations

Control Drug Status

• Not a controlled substance; it is a prescription / professional-use medication

Quick Tips

• High-dose injections are tools for repletion, not for frequent long-term use

• Always monitor calcium, vitamin D levels, and kidney function post-administration

• Avoid combining with high calcium supplements immediately

• Be alert for symptoms of hypercalcemia

• Use under medical supervision, particularly in patients with comorbid conditions